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Abstract 
Living organisms are endowed with the capability to tackle various forms of cellular 
stress due to the presence of molecular chaperone machinery complexes that are 
ubiquitous throughout the cell. During conditions of proteotoxic stress, the 
transcription factor heat shock factor 1 (HSF1) mediates the elevation of heat shock 
proteins, which are crucial components of the chaperone complex machinery and 
function to ameliorate protein misfolding and aggregation and restore protein 
homeostasis. In addition, HSF1 orchestrates a versatile transcriptional program that 
includes genes involved in repair and clearance of damaged macromolecules and 
maintenance of cell structure and metabolism, and provides protection against a broad 
range of cellular stress mediators, beyond heat shock. Here, we discuss the structure 
and function of the mammalian HSF1, and its regulation by post-translational 
modifications (phosphorylation, sumoylation, and acetylation), proteasomal 
degradation, and small molecule activators and inhibitors. 
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Introduction 
In the early 1960s, the Italian researcher Ferruccio Rittosa was studying the type(s) of 
nucleic acid that was being transcribed at the puffs in the chromosomes of the 
Drosophila salivary glands, where these chromosome puffs were found to be 
transcriptionally active regions [1]. By accident, one of his colleagues had increased 
the temperature of the incubator where he had kept his Drosophila larvae and during 
this time, Ritossa noticed a unique puffing pattern in the Drosophila polytene 
chromosomes when they were exposed to heat, sodium salicylate or dinitrophenol [2]. 
Subsequently, independent groups observed this phenomenon in other Drosophila 
tissues, and this ultimately led to the discovery of the heat shock proteins when 
Tissieres and colleagues found these proteins to be upregulated during the 
chromosomal puffing that occurred upon heat stress [3].  
In all living organisms, the cellular response to elevated temperatures is 
universal, and is triggered by a temperature increase of just a few degrees above the 
optimal temperature. Cells within these organisms possess intricate mechanisms that 
allow for adaptation and survival during elevated temperatures. In humans, 
temperatures above 41-42 °C induce the heat shock response (HSR), which is 
characterized by the activation of transcription of heat shock protein (Hsp) genes 
orchestrated by a family of transcription factors, within which heat shock factor 1 
(HSF1) is most prominent. The HSR causes the elevation of heat shock proteins such 
as Hsp27, Hsp40, Hsp70 and Hsp90, most of which are molecular chaperones that 
function to prevent protein misfolding and aggregation within the cell. The HSR is a 
cytoprotective mechanism that is also stimulated upon cellular stresses such as 
hypoxia [4], fluctuations in intracellular pH [5], and exposure to heavy metals [6, 7]. 
In addition to providing an adaptive response to thermal stress resulting in 
thermotolerance, the HSR orchestrated by HSF1 has protective effects in numerous 
pathophysiological conditions, including ageing and neurodegenerative diseases [8]. 
This is because HSF1 has a large number of target genes encoding proteins with 
versatile cytoprotective functions. Global transcriptional profiling, differential display, 
and proteomic approaches have revealed that, in different organisms, approximately 
50–200 genes are induced by heat shock [9]. These include the classical molecular 
chaperones that prevent unspecific aggregation of non-native or partially misfolded 
proteins, proteolytic proteins that can eliminate or recycle irreversibly-damaged 
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proteins which cannot be refolded by the chaperones, RNA- and DNA-modifying 
enzymes which participate in DNA damage repair, proteins involved in sustaining 
cellular structures such as the cytoskeleton and membranes, and proteins which 
participate in transport and detoxification. In addition, heat shock upregulates a 
number of metabolic enzymes that are needed to reorganize and maintain the energy 
supply of the cell. Induction of other transcription factors, kinases and phosphatases 
also occurs following heat shock, and may further activate other stress response 
pathways, thus amplifying the initial signal.  
Notably, not all genes are induced at the same time and with the same 
duration: some, such as those responsible for the correct protein folding, are 
immediate responders (within minutes), whereas others, such as those involved in 
DNA damage repair and cell metabolism, are somewhat slower (within hours) [9]. 
Overall, induction of the HSR provides broad protection against stress of various 
different types, including and extending beyond heat shock. A study in the nematode 
C. elegans has shown that activation of Hsp90 in response to an imbalance in 
proteostasis in one tissue functions in a non-autonomous fashion termed transcellular 
chaperone signaling to initiate a protective response in adjacent tissues and restore the 
protein homeostasis within the whole organism [10]. In agreement, excitation of 
serotonergic neurons in C. elegans with the consequent release of serotonin is 
sufficient to activate HSF1 and the HSR, and to suppress protein misfolding in 
peripheral tissues even in the absence of temperature increase [11]. It will be 
important to determine whether similar signaling mechanisms operate in mammals. 
 
HSF Family Members 
To date, four members belonging to the HSF protein family have been identified, of 
which HSF1, HSF2 and HSF4 [12, 13] have been characterized in mammals, whereas 
HSF3 was initially identified in the avian species [14]. The human, mouse and bovine 
HSF1 share approximately 84% sequence identity (Fig. 1 and Fig. 2). The 
mammalian HSF2 and HSF4 are also well conserved across species, sharing 
approximately 88% and 79% amino acid sequence identity, respectively. In humans, 
the amino acid sequence of HSF1 shares 32% and 36% sequence identity to HSF2 
and HSF4, respectively.  
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In unstressed cells, HSF1 is a monomer and in contrast, HSF2 is a dimer. 
Upon stress, HSF2 can either form a homotrimer or it can heterotrimerize with HSF1 
in the nucleus and induce the transcription of both the classical heat shock genes as 
well as non-classical heat shock genes such as the tandem satellite III DNA repeats 
[15, 16]. A recent study has discovered that HSF1 and HSF2 interact with each other 
through their coiled-coil domains adjacent to their DNA binding domains [17]. Unlike 
HSF1, HSF2 expression is tissue- and cell-specific [18]. In the mouse, HSF2 plays a 
vital role in spermatogenesis, female fertility and early development [19, 20]. Kallio 
et al. discovered that HSF2-knockout (HSF2-/-) mice, although embryonically viable, 
display brain abnormalities, which are characterized by a reduced striatum and 
hippocampus; furthermore, HSF2-/- female mice produce eggs with meiotic defects 
[20]. Although much of the early research on HSF2 was focused on its role in 
development, a study by Shinkawa et al. [21] has highlighted the link between HSF2 
and neurodegeneration. These researchers found that loss of HSF2 in the R6/2 
Huntington’s disease mouse model exacerbates the aggregation of the polyglutamine 
protein leading to decreased lifespan, partly through increased expression of the small 
heat shock protein αB-crystallin.  
HSF4 lacks the LZ4 domain (see below) that is required for the suppression of 
trimerization of HSF1, is localized mainly in the nucleus, and is ubiquitously 
expressed. HSF4 plays an important role in development and its expression is 
increased during lens development [22]. Many studies have shown that HSF4 is 
crucial for the development and maintenance of the lens as mutations in HSF4, 
particularly in the DNA-binding domain, are correlated with the development of 
cataracts in humans [23-26]. One of the isoforms of HSF4, HSF4a, has been shown to 
negatively regulate HSF2 by downregulating the expression and inhibiting the 
transcriptional activity of HSF2 at the hsp70 promoter via direct binding to HSF2 [27]. 
Loss of the ATP-dependent chromatin remodelling enzyme Snf2h is vital for lens 
development in mice. Interestingly, depletion of Snf2h dramatically reduces HSF4 
transcript levels suggesting that the transcription factor is regulated by chromatin 
remodelling, and that the role of Snf2h in lens development might be in part mediated 
by HSF4 [28]. 
The mammalian HSF1 ortholog in avian cells is functionally redundant, 
however in the chicken, HSF3 is the major heat shock transcription factor [29]. 
Furthermore, human HSF1 is able to rescue the induction of the classical heat shock 
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responsive genes in the absence of chicken HSF3, although chicken HSF1 confers 
cellular cytoprotection when cells are exposed to stressors such as ionizing or 
ultraviolet irradiation [30]. Interestingly, this occurs without inducing the classical 
heat shock genes, suggesting that chicken HSF1 also plays a role in other pro-survival 
pathways. In the chicken, HSF3 exists as a dimer in unstressed cells and is able to 
form homotrimers upon heat shock [14, 31]. The mouse HSF3 discovered in 2010 by 
Fujimoto et al. [32] can activate the transcription of non-classical heat shock genes in 
HSF1-knockout mouse embryonic fibroblasts (MEF) cells, and its isoform mHSF3a, 
has the ability of protect cells from heat shock and proteotoxicity. Of note, although 
HSF3 is considered to be the avian ortholog of the mammalian HSF1, one study 
suggests its involvement in the regulation of a number of febrile response mediators, 
such as the interleukins IL-6. IL-1β, and activating transcription factor 3 (ATF3) [33]. 
 
HSF1 
HSF1 is the most well studied member of the HSF family. During unstressed 
conditions, the mammalian HSF1 exists as a monomer more abundantly in cytoplasm 
relative to the nucleus (Fig. 3). The DNA-binding and transcriptional capacity of 
HSF1 is suppressed at the intramolecular level as well as the intermolecular level, 
where in the latter, molecular chaperones such as Hsp70 [34], Hsp90 [35], and 
TRiC/CCT [36] interact with HSF1 to inhibit its activation. Upon cellular tress, HSF1 
undergoes several activating post-translational modifications and forms a 
transcriptionally active trimer that accumulates in the nucleus and binds to heat shock 
elements (HSE), inverted repeats of the pentameric sequence nGAAn that are found 
in the upstream regulatory regions of the hsp genes [37]. By use of fluorescence 
polarization and thermal denaturation profiling combined with quantitative chromatin 
immunoprecipitation assays, Jaeger et al. [38] have demonstrated a role for specific 
orientations of extended HSE sequences in driving preferential HSF1 DNA binding to 
its target loci. 
Nuclear stress bodies (nSB) are relatively large distinct structures (0.3 to 3 µm 
in diameter) that are formed in the nucleus when the cell is exposed to stress such as 
heat shock or heavy metals [39]. The formation of nSB requires the transcriptionally 
active HSF1 to interact with pericentrometric tandem repeats of satellite III sequences 
within the 9q12 chromosomal locus leading to the transcription of non-coding single-
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stranded RNA molecules, which have been proposed to function by recruiting specific 
factors and affecting chromatin organization. Also, HSF1 binds to the histone acetyl 
transferase (HAT) CREB and causes the hyperacetylation of nucleosomes at the 
satellite III repeats, allowing RNA polymerase as well as several RNA-binding 
proteins to transcribe sat III mRNA transcripts. The mRNA and RNA-binding protein 
complexes generated are known as the perichromatin granules and are generated in 
large clusters during stress forming mature distinct nSB [40].  Interestingly, at the 
nSB, HSF1 and HSF2 form transcriptionally active heterocomplexes [41], and the 
formation of nSB coincides with the nucleolar accumulation of Hsp70. Although, the 
function of the nSB is currently not clear, it is noteworthy that upon stimulation, nSB 
are formed as early as 5 minutes and they are able to persist for several hours after the 
initial stimulation. During the heat shock response, Hsp70 levels are increased, and 
the HSF1 trimers that exit the nSB are dissociated into inactive HSF1 monomers by 
the binding of Hsp70 [40].  
The generation of HSF1-knockout mice (HSF1-/-) provided important insights 
into the functional significance of HSF1 [42, 43]. HSF1-/- mice have altered redox 
homeostasis in the cardiac cells, and their mitochondria are highly susceptible to 
oxidative damage. It was found that HSF1 is essential for induction of the classical 
heat shock genes, and HSF1-/- MEF cells are more sensitive to apoptosis during heat 
stress compared to their wild-type counterparts, showing the importance of HSF1 for 
cell survival. Female HSF1-/- mice display placental insufficiency, which contributes 
to the partial fetal lethality of the absence of the transcription factor. Male HSF1-/- 
mice are fertile, however the females with this genotype are sterile. HSF1 plays a vital 
role in oogenesis: HSF1 is highly abundant in the nucleus of immature oocytes and 
plays an important role in the initial cleavage stages, hence explaining the infertility 
described in the HSF1-/- females [44]. 
 
Post-translational Modifications of the HSF1 protein 
HSF1 is constitutively expressed in most tissues and cell types and is regulated by 
multiple post-translational modifications (PTM) such as sumoylation, acetylation and 
phosphorylation (Fig. 4) throughout its activation and attenuation cycle. In an 
unstressed system, HSF1 is a monomeric phosphoprotein where it is phosphorylated 
on multiple serine residues [45-48], and is also negatively regulated at the 
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intramolecular level due to the binding of the leucine zipper (LZ)1-3 domain and the 
LZ4 domain. The LZ1-3 domain, or the oligomerization domain, due to its coiled-coil 
structure has the ability to form homotrimers [49-51]. Upon stress, the intramolecular 
coiled-coil interaction is lost and an intermolecular coiled-coil interaction is 
established. In addition, phosphorylation on serine 303 that lies within the regulatory 
domain of HSF1 is required for sumoylation [conjugation of small ubiquitin modifiers 
(SUMO) 2/3] at lysine 298 [52], and this mechanism was first described in HSF1, 
where phosphorylation-dependent sumoylation motif (PDSM) characterized by the 
consensus sequence ΨKxExxSP (where Ψ is a branched hydrophobic amino acid and 
x is any amino acid) was identified [53]. Sumoylation at lysine 298 renders HSF1 
transcriptionally incompetent [54]. Phosphorylation of serine 303 and 307 itself does 
not affect the transcriptional activity of HSF1; however, the phospho-S303-dependent 
sumoylation on lysine 298 blocks its transactivation capacity [55]. 
The DNA-binding domain (DBD) (Fig. 1, Fig. 4 and Fig. 5) located at the N-
terminal region of HSF1 is highly conserved across species [8]. Within the HSF1 
trimers, each of the DBD of the monomers recognizes the nGAAn sequence in the 
major groove [56, 57]. Phosphorylation of serine 121 by mitogen-activated protein 
kinase (MAPK)-activated protein kinase 2 (MAPKAPK2) at the DBD causes HSF1 to 
lose its transcriptional activity and promotes binding to its negative regulator Hsp90 
[58]. In addition, acetylation on lysine 80 hinders the transcriptional capacity of HSF1, 
as mutagenesis studies have revealed a loss-of-function phenotype when lysine 80 
was mutated [59-61]. Activation of the deacetylase sirtuin-1 (SIRT1) prolongs the 
transcriptional competency of HSF1, whereas the decrease in SIRT1 accelerates the 
attenuation phase of the HSR [61].  
The regulatory domain (RD) of HSF1 lies between the LZ1-3 and LZ4 
domains. Its absence causes HSF1 to become transcriptionally active even in 
unstressed conditions, which highlights the role of the RD as a repressor of HSF1 
activity and also as a stress sensor [62, 63]. The RD is subjected to many PTM such 
as acetylation, phosphorylation and sumoylation (Fig. 4). In 2005, Guettouche and 
colleagues performed an extensive study on the phosphorylation sites on human HSF1 
and identified that HSF1 was phosphorylated on multiple serine residues, and 
interestingly, they did not detect phosphorylation on threonine or tyrosine residues 
[64]; however, other groups have identified phosphorylation events occurring on such 
residues [65, 66]. Most phosphorylation modifications within the RD are inhibitory, 
Page 8 of 45The FEBS Journal
 9
and a mutant HSF1, where the 15 known phosphorylation sites within the RD are 
disrupted, is a potent transactivator of its target genes, with reduced activation 
threshold [67]. However, phosphorylations on serine 230 [47] and serine 326 [64, 68] 
are activating. Thus, the calcium/calmodulin-dependent kinase CAMKII 
phosphorylates HSF1 at serine 230 during stress conditions, and mutation of this 
residue reduces the transcriptional capacity of HSF1 [47]. The phosphorylation of 
serine 326 of HSF1 allows DAXX to bind to HSF1 to enhance its transcription [68], 
and mutations of serine 326 have been reported to reduce the transcriptional activity 
of HSF1 [64, 68]. Several kinases have been implicated in phosphorylating HSF1 at 
serine 326, including the mechanistic target of rapamycin (mTOR) [69], the mitogen-
activated protein kinase kinase MEK [70] and the p38 MAPK [71]. Notably, among 
the p38 MAPK family members, p38δ MAPK is a particularly efficient catalyst of 
this phosphorylation, whereas p38γ MAPK is the most specific [71]. 
The available literature on the functional characterization of the HSF1 C-
terminal transactivation domain (CTAD) is limited compared to the other domains 
described above. The CTAD consists of two transactivation domains, TAD1 and 
TAD2 [63]. TAD1 (amino acids 401-420) is rich in hydrophobic amino acids and 
interacts with TATA-box binding protein associated factor TAF9 in vitro, and 
mutations within the hydrophobic patch of TAD1 prevent HSF1 transactivating 
capability [72]. TAD2 contains both acidic and hydrophobic residues and is proline-
rich. BRG1 belonging to chromatin remodeler SWI/SNF complex binds to HSF1 at 
the CTAD [73]. It is likely that the CTAD could be the hub for interaction of 
transcriptional co-factors and HSF1. Interestingly, Hsp70 binds to the CTAD of HSF1 
[74], therefore, it could potentially negatively regulate HSF1 by disrupting the 
association of HSF1 with its transcriptional co-activators such as p300/CBP [75]. 
Although it is clear from the literature that HSF1 and Hsp90 interact [34, 35, 76], to 
our knowledge, the precise interaction site has not been mapped. 
 
HSF1 Protein Turnover 
The endogenous HSF1 protein has a relatively long half-life, in the range of 13.6 h to 
20 h [77-79]. Unlike the long half-life of the protein, the half-life of HSF1 mRNA is 
approximately 100 min [80]. It is highly likely that the reason for HSF1 being such a 
long-lived protein is to be readily available in the event of exposure to cytotoxic stress 
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so that it is able to exert its cytoprotective effects immediately. The histone 
acetyltransferase E1A Binding Protein P300 (EP300) promotes the stability of 
endogenously expressed HSF1 through acetylation on several of its lysine residues 
(i.e., lysine 208 and lysine 298) hence preventing it from being ubiquitinated and 
targeted for proteasomal degradation [81]. EP300 maintains HSF1 stability 
irrespective of its phosphorylation status [81].  
One of the first insights regarding HSF1 turnover was provided by Bonelli and 
colleagues who found that only under heat shock conditions, serum-starved late 
passage human fibroblast cells displayed reduced HSF1 levels compared to early 
passage serum-starved cells [82]. This finding is further supported by a recent 
publication showing that HSF1 degradation increases dramatically post-heat shock 
and furthermore, RNAi-mediated depletion of the proteasomal subunit PSMA7, 
prolonged the Hsp70 mRNA production by approximately 5 h under conditions of 
heat shock suggesting that the HSR is attenuated by the proteasome [81]. Interestingly, 
riluzole which is the only FDA-approved drug for the treatment of the 
neurodegenerative disease amyotrophic lateral sclerosis, is able to dramatically 
increase the protein half-life of endogenous HSF1 from 13.6 h to 69.3 h [78], 
allowing greater activation of the HSR in cancer and neuronal cells [78, 83]. 
Furthermore, silencing LAMP2A using RNAi, curbed the turnover HSF1 in the 
presence of riluzole which suggests that the compound could potentially block the 
clearance of HSF1 through chaperone-mediated autophagy as LAMP2A is an 
essential potentiator of this process [78].  
Until recently, not much was known about the mechanisms by which HSF1 is 
degraded, however, studies have emerged implicating several proteins that mediate 
the degradation of HSF1, namely, filamin interacting protein 1-like (FILIP-1L) and 
the E3 ligases, SCFβ/TrCP, F-Box and WD repeat domain containing protein 7 
(FBXW7) and neural precursor cell expressed developmentally down-regulated 
protein 4 (NEDD4). FILIP-1L was identified as a binding partner of HSF1 through a 
yeast-two-hybrid screen [84]. The downregulation of FILIP-1L has been implicated in 
various human tumours and has been linked with hypermethylation at the FILIP-1L 
gene promoter and to global DNA methylation [85, 86]. Hu and Mivechi showed that 
overexpression of FILIP-1L leads to the decrease in HSF1 levels and as a 
consequence inhibits the transcription of HSF1 target genes. They further found that 
FILIP-1L acts as an adaptor protein for HSF1 to allow for binding to hHR23A, an 
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ubiquitin receptor protein that functions to transfer ubiquitinated proteins to the 19S 
proteasome [84].  
As described in the previous section, phosphorylation of HSF1 at serine 216 
targets the protein for degradation by the E3 ubiquitin ligase SCF/β-TrCP during 
mitosis, and mutation of this residue to arginine, dramatically increases its half-life 
[87]. FBXW7 is the substrate recognition component of the SCF ubiquitin ligase 
complex and in humans it functions as a tumour suppressor as it mediates the 
degradation of many proto-oncogenes such as MYC, NOTCH and JUN [88]. FBXW7 
binds to its substrates via their phosphodegron motifs which are called Cdc4 
phosphodegrons, where phosphorylation within the phosphodegrons has to occur in 
order for binding to take place [88]. In most cases, FBXW7 substrates such as the 
ones mentioned above are phosphorylated by GSK3 within the phosphodegron. 
Interestingly, a recent article has linked the protein stability of HSF1 to FBXW7α; the 
authors reported that the SCF/FBXW7 complex targets the degradation of HSF1 
through direct binding at the phosphodegron motif spanning serine 303 and serine 307, 
where GSK3 and ERK1 phosphorylate these sites respectively [79]. The 
phosphorylation of serine 303 and serine 307 is required for the binding of FBXW7α 
to HSF1, and loss of FBXW7α causes persistent nuclear accumulation and activation 
of HSF1. In human melanoma cells, FBXW7α is downregulated, and Kourtis and 
colleagues showed that HSF1 accumulation and activation drives the metastatic 
potential [79]. GSK3 is activated under low-serum or serum-starved conditions [89, 
90]. Taken together, the observations by Bonelli et al. and Kourtis et al. suggest that 
during serum starvation, heat shock could cause the activation of GSK3 and 
subsequent phosphorylation of HSF1 at the serine 303 and serine 307 phosphodegron 
to allow for SCF/FBXW7-mediated degradation of the transcription factor [79, 82].  
Numerous reports have linked the loss of HSF1 to the promotion of 
neurodegenerative diseases [91, 92]. α-Synucleinopathies represent progressive 
neurodegenerative diseases such as Parkinson’s disease, multiple system atrophy and 
dementia with Lewy bodies [93, 94] where there is accumulation of α-synuclein in the 
cytoplasm of a subset of neuronal and glial cells. A53T α-synuclein is able to form 
aggregates more readily than WT α-synuclein. In a recent study, Kim et al. found that 
overexpression of the mutant A53T α-synuclein in neuronal cells caused a decrease in 
HSF1 protein levels of more than 70% compared to WT α-synuclein whilst not 
affecting the HSF1 mRNA levels [95]. WT α-synuclein caused the decrease of HSF 
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levels in the nucleus unlike the mutant A53T α-synuclein which decreased HSF1 
levels in both the nucleus and cytoplasm [95]. Furthermore, A53T α-synuclein 
overexpression increased the amount of ubiquitinated HSF1. Because the authors had 
previously identified the E3 ligase NEDD4 levels to be elevated in brains from 
Parkinson’s disease patients [96], they overexpressed NEDD4 in neuronal cells and 
observed a prominent decrease in HSF1 protein levels [95]. Conversely, loss of 
NEDD4 or the overexpression of HSF1 was neuroprotective against α-
synucleinophathy [95]. 
 
Small Molecule Activators of HSF1 
Numerous small molecules, both endogenously occurring as well as of exogenous 
origin, have been shown to activate HSF1 (see West et al. [97] for a comprehensive 
review). In most cases, these compounds are inducers of the transcriptional activity of 
HSF1. Here we give examples of endogenous metabolites as well as phytochemicals, 
which have been isolated from edible and/or medicinal plants, and are contributing to 
the health-promoting effects of plant-rich diets. We then describe the synthetic HSF1 
activators, which have been identified using reporter systems and high-throughput 
screening strategies. The chemical properties of these compounds have provided 
important insights into the mechanisms of activation of the HSR. In particular, 
sulfhydryl reactivity, a characteristic feature of many HSF1 activators, underlies their 
ability to affect the function of HSF1 and some of its critical regulatory proteins, such 
as Hsp90, SIRT1, or upstream regulatory kinases [98].  
 
Endogenous metabolites 
HSF1-mediated transcription is induced by endogenously produced electrophilic 
oxidized and nitrated lipids, as well as α,β-unsaturated aldehydes. Examples include 
4-hydroxy-2-nonenal, acrolein, 10-nitro-octadecenoic acid (nitro-oleic acid), and 15-
deoxy-∆
12,14
-prostaglandin J2 (15d-PGJ2) (Fig. 6). Nuclear accumulation of HSF1 and 
induction of Hsp70 and Hsp40, as well as of HSE-dependent luciferase reporter, have 
been observed when human colon cancer cells were exposed to 4-hydroxy-2-nonenal, 
and siRNA-mediated silencing of HSF1 abolished this induction [99]. Treatment of 
human endothelial cells with 10-nitro-octadecenoic (nitro-oleic) acid, a nitrated 
product of oleic acid with cytoprotective activities, led to activation of the heat shock 
Page 12 of 45The FEBS Journal
 13
response [100]. Induction of Hsp70 and Hsp40 also occurred when A549 human lung 
cancer cells were exposed to the electrophilic lipid peroxidation product acrolein 
[101]. The DNA binding activity of HSF1 was increased and the expression of Hsp70 
was robustly upregulated by 15d-PGJ2 in the heart of male Wistar rats undergoing 
ischemia-reperfusion injury [102]. Interestingly, high concentrations of 17β-estradiol 
have been shown to activate HSF1 and induce Hsp70 [103, 104]. Unlike the other 
endogenous HSF1 activators mentioned above, 17β-estradiol is not electrophilc; 
however, it can be metabolically converted to the electrophilic quinone derivatives 2-
hydroxy- and 4-hydroxy-estradiol [105], which might be the ultimate inducers. 
In addition to endogenous electrophiles, the HSF1-mediated HSR is directly 
activated by the oxidant hydrogen peroxide (H2O2). Interestingly, in this case, HSF1 
itself is the protein sensor as activation of murine HSF1 by H2O2 is dependent on 
cysteine 35 and cysteine 105, which form a disulfide bridge [106]. The corresponding 
pair of cysteines (i.e., cysteine 36 and cysteine 103) in human HSF1 form an 
intermolecular disulfide bridge, promoting HSF1 trimerization and binding to the 
HSE [107]. A subsequent study has shown that an intermolecular interaction between 
the aromatic residues tryptophan 37 and phenylalanine 104 supports the approach of 
cysteine 36 and cysteine 103 [108]. In contrast, an intramolecular disulfide bridge 
formation (in which cysteine 153, cysteine 373 and cysteine 378 participate) inhibits 
trimerization and DNA binding of HSF1 [107]. The signalling molecule nitric oxide 
has been reported to activate HSF1 and induce Hsp70 in vascular smooth muscle cells 
[109]. Interestingly, S-nitrosation at cysteine 597 of human Hsp90α inhibits the 
ATPase activity of the chaperone [110], and substituting cysteine 597 with S-
nitrosation-mimicking residues, such as asparagine and aspartic acid, shifts the 
conformational equilibrium of the chaperone, decreasing its activity [111]. It is 
therefore possible that HSF1 activation by nitric oxide is due to inactivation of Hsp90. 
Activation of HSF1 can also be stimulated by electrophilic and reactive 
oxygen species which are formed during physiological and pathophysiological 
processes. Thus, HSF1 is activated in atherosclerotic lesions, and cytokine stimulation 
and mechanical stretching of smooth muscle cells result in HSF1 
hyperphosphorylation, nuclear translocation, and enhanced Hsp70 expression [112]. 
In addition, HSF1 activation has been implicated in the production of plasminogen 
activator inhibitor-1 after stimulation by glycated low density lipoproteins as well as 
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by oxidized very low density lipoproteins in cultured vascular endothelial cells [113, 
114]. Subsequent studies have shown that in this case, activation of HSF1 is mediated 
by induction of NADPH oxidase, implicating supreoxide as the ultimate activator 
[115, 116]. 
 
Phytochemicals 
A screen of bioactive small molecules in the human cervical cancer HeLa cell line 
that is stably transfected with a luciferase-encoding construct under the transcriptional 
control of the HSP70 promoter has identified the phytochemical celastrol as inducer 
of the HSR [117]. Celastrol is a quinone methide triterpenoid (Fig. 7) found in the 
Chinese plant Tripterygium wilfordii. In addition to the HeLa reporter cell line, 
celastrol activates the hsp70 promoter reporter in the breast cancer cell lines MCF7 
and BT474, the nonsmall cell lung carcinoma cell line H157, and the neuroblastoma 
cell line SH-SY5Y), and importantly, the magnitude of activation is comparable to 
that induced by heat shock (42°C) [117]. In agreement, exposure to celastrol is 
protective against lethal heat stress, and to a similar extent as a 42 °C heat shock. 
Treatment with celastrol leads to hyperphosphorylation of HSF1, enhanced binding of 
HSF1 to the HSE, and transcriptional activation of endogenous heat shock genes 
[117]. Subsequent studies have suggested that inhibition of Hsp90 by celastrol may be 
the initial event that triggers dissociation of HSF1 from the protein complex [118, 
119]. This possibility is further supported by mechanistic studies showing that 
celastrol reacts with Hsp90 and inhibits the ATPase activity of the chaperone without 
affecting ATP binding [71, 120].  
The tetranortriterpenoid gedunin (Fig. 7) from the Indian neem tree 
Azadirachta indica is another activator of HSF1. Compared to celastrol, gedunin is 
less potent, but appears to use similar mechanisms by which it activates HSF1, i.e. 
inhibition of the function of the negative regulator Hsp90 [119, 121]. The use of a 
high content screening platform, an image-based, multiparametric assay which 
monitors the formation of HSF1/Hsp70 stress granules in heat-shocked HeLa cells, 
identified four compounds closely related to gedunin, i.e., deoxygedunin, deacetoxy-
7-oxogedunin, deacetylgedunin, and sappanone A, which were subsequently 
confirmed to activate HSF1 and induce Hsp70 in an HSF1-dependent manner [122].   
Withaferin A (Fig. 7), a withanolide found in the Indian plant Withania 
somnifera, was identified in a screen of a library of more than 80,000 natural and 
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synthetic compounds using a reporter cell line which expresses enhanced green 
fluorescent protein (EGFP) under the transcriptional control of a minimal consensus 
HSE-containing promoter [123]. Like celastrol and gedunin, withaferin A also 
inhibits the function of Hsp90 [124, 125], and this inhibition may be responsible for 
activation of HSF1. The same high-throughput screen confirmed that celastrol, 
withaferin A, gedunin are all inducers of the HSR, and identified several other natural 
products, such as the limonoids anthothecol, cedrelone, and the gedunin derivative 7-
desacetoxy-6,7-dehydrogedunin, as well as a fungal product, the macrocyclic lactone 
dehydrocurvularin among the active compounds [123]. Notably, all of these 
compounds have an α,β-unsaturated carbonyl functional group, emphasizing the 
importance of electrophilicity for inducer activity. 
Curcumin [1,7-bis(4-hydroxy 3-methoxy phenyl)-1,6-heptadiene-3,5-dione, 
diferuloylmethane, Fig. 7], a polyphenol from the East Indian plant Curcuma longa,  
has been shown to induce heat shock proteins in numerous cell culture and animal 
models [126, 127]. The observed disruption of the binding of the Hsp90-p23 complex 
to its client protein p210 BCR/ABL, and the consequent degradation of the kinase in 
chronic myelogenous leukemia cells upon exposure to curcumin [128] suggests that, 
for this compound too, induction of heat shock proteins could be a consequence of 
inhibition of Hsp90 function. Notably, curcumin has been present in the human diet 
for centuries, and there is a wealth of information regarding its safety and efficacy in 
both animals and humans [129]. To date, more than 100 clinical trials have been 
registered to evaluate this polyphenol in a number of conditions, including mild 
cognitive impairment, Alzheimer’s disease, multiple myeloma, pancreatic cancer, 
colorectal cancer, and myelodysplastic syndrome (www.clinicaltrials.gov). 
Coniferyl aldehyde (Fig. 7) is a phenolic compound, which is found as a 
glucoside in the bark of Eucommia ulmoides, a plant that is used in the traditional 
medicine of Korea, Japan, and China. Coniferyl aldehyde has been shown to increase 
the protein stability of HSF1, activate the mitogen-activated protein kinases 
extracellular signal-regulated kinases (ERK)1/2, c-Jun N-terminal kinase (JNK)1, and 
p38, promote HSF1 phosphorylation at serine 326, and consequently upregulate the 
expression of Hsp27 and Hsp70 [130]. Furthermore, the same study showed that 
coniferyl aldehyde treatment protected cells and mice against damage induced by 
ionizing radiation or taxol, but was not effective in HSF1-/- cells, demonstrating the 
essential requirement for HSF1 for the protective activity of this phytochemical [130]. 
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Another aromatic phytochemical, the chalcone derivative (±)-4,2',4'-
trihydroxy-3'-[(6E)-2-hydroxy-7-methyl-3-methylene-6-octenyl]chalcone (Fig. 7), 
was also reported to activate HSF1-dependent transcription in human lung cancer 
NCI-H460 cells [131]. In an effort towards identification of heat shock protein-
inducing agents from natural products, this chalcone was isolated from the areal parts 
of Angelica keiskei Koidzumi (Umbelliferae), an edible plant that is considered health 
food in Korea and Japan [131].  
Sulforaphane [1-isothiocyanato-(4R)-(methylsulfinyl)butane, Fig. 7] is an 
isothiocyanate which is formed from a glucosinolate precursor (glucoraphanin) upon 
plant tissue injury. Importantly, cruciferous vegetables, such as broccoli (Brassica 
oleracea), are rich dietary sources of this phytochemical. Nuclear accumulation of 
HSF1 and induction of heat shock proteins by sulforaphane treatment has been 
demonstrated in several cell culture models, including human cell lines, as well as in 
animals after a single oral dose of the isothiocyanate [132-134]. Another 
isothiocyanate, phenethyl isothiocyanate (Fig. 7), which occurs in watercress 
(Nasturtium officinale), has also been shown to induce expression of heat shock 
proteins in cultured cells and animals [71, 135]. Phenethyl isothiocyanate inhibits 
Hsp90, activates p38 MAPK, increases the phosphorylation of HSF1 at serine 326, 
and robustly upregulates HSE-mediated transcription of endogenous as well as 
reporter genes [71]. Similarly, the levels of Hsp70 are robustly upregulated upon 
exposure of cells to the aromatic benzyl isothiocyanate, but not the aliphatic allyl 
isothiocyanate [71].  
The available experimental evidence points to Hsp90 as the main intracellular 
target of the isothiocyanates to facilitate HSF1 activation: (i) co-treatment with 
sulforaphane enhances the anti-tumor effect of the Hsp90 inhibitor 17-allylamino 17-
demethoxygeldanamycin (17-AAG) [136]; (ii) sulforaphane disrupts the interaction of 
Hsp90 with its co-chaperone Cdc37 [136]; (iii) synergistically with 17-AAG, the 
isothiocyanate downregulates several Hsp90 client proteins, such as mutant p53, Raf-
1, and Cdk4 [136], (iv) Hsp90 is covalently modified by a sulfoxythiocarbamate 
derivative of sulforaphane both in vitro and in cells [137-139], (v) the fraction of 
Hsp90-bound HSF1 is smaller in lysates from cells that had been treated with 
phenethyl isothiocyanate compared to solvent-treated cells, suggesting dissociation of 
HSF1 from Hsp90  [71], and (vi) the ability of sulforaphane to downregulate the 
activity of histone deacetylase (HDAC) [140-144] may further inhibit the activity of 
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Hsp90 through altering acetylation of the chaperone. Indeed, inhibition or knockdown 
of HDAC6 leads to acetylation of Hsp90 and disruption of its chaperone function 
[145], and treatment with sulforaphane downregulates the activity of HDAC6, 
resulting in hyperacetylation of Hsp90 [144].  
In contrast to the electrophilic phytochemicals discussed above, the stilbene 
resveratrol (Fig. 7) appears to activate HSF1 by promoting the persistent DNA 
binding of the transcription factor and suppressing the attenuation phase of the HSR 
[61]. In this case, the phytochemical functions by activating the NAD
+
-dependent 
deacetylase SIRT1 and thus maintaining HSF1 in a deacetylated, DNA-binding 
competent state. Resveratrol directly activates SIRT1 through an allosteric 
mechanism resulting in the lowering of the Km for both the acetylated protein 
substrate and for the cofactor NAD
+
[146]. Most small-molecule SIRT1 activators 
known to date are planar molecules comprised of multiple phenyl rings bearing 
hydroxyl groups [146]. Whether other phytochemicals which are known to activate 
SIRT1, such as the flavonol fisetin and the chalcone butein [147], could have a 
similar effect on HSF1 is presently unknown. 
An important aspect of the biological activities of many of the phytochemicals 
discussed here is that exposure of cells and organisms to these compounds often 
results in non-linear dose responses. This is in line with the concept of hormesis, 
which is characterized by a low-dose stimulation and a high-dose inhibition, resulting 
in either a J-shaped or an inverted U-shaped dose response [148, 149]. Ingestion of 
phytochemicals such as curcumin can initiate mild cellular stress involving free 
radical production, ion fluxes, and increased energy demand [150, 151]. This is 
followed by activation of adaptive stress response pathways, such as those regulated 
by HSF1, leading to transcriptional induction of cytoprotective proteins, and 
ultimately enabling cell survival. Importantly, once mounted, the hormetic response is 
protective against more severe stress conditions, which otherwise may be lethal. In 
addition, this protection is not limited to higher doses of the same stress agent, but 
extends to other types of stressors, including oxidative, metabolic, and thermal stress. 
 
 
 
Synthetic compounds 
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The possibility of developing small molecule activators of the HSR as 
pharmacological agents for protection against human diseases, especially protein 
conformational diseases, has led to the development of several high-throughput 
screening strategies. Neef et al. have reported the development of a humanized yeast-
based high-throughput screen, which is insensitive to proteotoxic stress and Hsp90 
inhibition, and identified two potent small-molecule activators of human HSF1 within 
a chemical library of over 10,000 compounds [152]. These HSF1 activators (named 
HSF1A and HSF1C) are benzyl pyrazole derivatives (Fig. 8). The more potent 
compound, HSF1A, was then shown to activate HSF1 and induce Hsp70 in HeLa 
cells as well as in wild-type, but not in HSF1-deficient mouse embryonic fibroblasts. 
In contrast to the electrophilic HSF1 activators, pre-incubation with dithiothreitol had 
no effect on the inducer activity of HSF1A. A subsequent study has revealed that 
HSF1A functions by binding to and inhibiting the function of one of the negative 
regulators of HSF1, i.e. TRiC/CCT, an ATP-dependent chaperonin complex, thereby 
disrupting the interaction between TRiC/CCT and HSF1, and consequently leading to 
HSF1 activation [36]. 
Calamini et al. have conducted a mammalian cell-based high-throughput 
screen for HSR activation by cell-permeable small molecules in HeLa cells stably 
transfected with a luciferase reporter gene under the transcriptional control of the 
proximal human HSP70.1 promoter sequence [153]. Approximately 900,000 
compounds were screened, and ~200 small molecule activators of the HSR were 
found. Electrophilicity is a common feature among many, although not all, active 
compounds. A cyclohexanone derivative (named compound A1) containing the 
electrophilic α,β-unsaturated carbonyl groups is closely related to 
bis(benzylidene)acetone and bis(2-hydroxybenzylidene)acetone (Fig. 8), two 
structurally similar compounds, which however differ greatly in inducer potency 
[138]. Inducer potency correlates with sulfhydryl reactivity: compared to the 
hydroxylated analogue, bis(2-hydroxybenzylidene)acetone, a robust HSF1 activator 
[138], the parent compound bis(benzylidene)acetone reacts more slowly with the 
sulfhydryl groups of glutathione and dithiothreitol [154], and is essentially inactive as 
an Hsp70 inducer [138]. The electrophilic acetylenic bis(cyano enone) (±)-
(4bS,8aR,10aS)-10a-ethynyl-4b,8,8-trimethyl-3,7-dioxo-3,4b,7,8,8a,9,10, 10a-
octahydrophenanthrene-2,6-dicarbonitrile (TBE-31) (Fig. 8) that reacts readily and 
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reversibly with sulfhydryl groups [155], is another inducer of Hsp70, which is active 
at high nanomolar concentrations in wild-type, but not in HSF1-/- MEF cells [138]. 
The mildly electrophilic sulfoxythiocarbamate analogues of the isothiocynate 
sulforaphane constitute another class of synthetic HSF1 activators. 
Sulfoxythiocarbamate alkyne (STCA) (Fig. 8), which forms stable adducts with 
sulfhydryl groups [137], forms adducts with cysteine 412, cysteine 564, and cysteine 
589/590 of recombinant Hsp90, and activates HSF1-mediated transcription of a 
luciferase reporter as well as of the endogenous Hsp70 in mammalian cells of many 
different types, including MEFs, HeLa, and MCF7 cells [139]. 
Pyrrolidinedithiocarbamate and 1,2-dithiole-3-thione are two other activators of 
HSF1-mediated induction of Hsp70 [156, 157], which have the ability to react with 
sulfhydryl groups. Activation of HSF1 and induction of the HSR has also been 
reported to occur upon exposure of cells to pro-electrophilic oxidizable diphenols; in 
this case, the corresponding oxidized electrophilic metabolites are the ultimate 
inducers [158]. 
 
Small Molecule Inhibitors of HSF1 
Due to the ability of HSF1 to promote cancer cell survival and metastasis in animal 
models, its frequent activation in human tumors, and correlation with poor patient 
prognosis [159, 160], the discovery of small molecule HSF1 inhibitors and their 
development as anticancer drug candidates are actively being pursued [161]. Using a 
gel shift assay Nagai et al. [162] reported that the flavonoid quercetin (3,3',4',5,7-
pentahydroxyflavone) (Fig. 9) inhibits the binding of HSF1 to its promoter HSE 
sequences without affecting the ability of the transcription factor to form trimers. The 
group further found that quercetin caused a decrease in the levels of phosphorylated 
HSF1, and that this decrease was more apparent in heat-shocked cells than in control 
cells. A later study confirmed that quercetin caused depletion of HSF1 and inhibition 
of heat shock protein expression in neuroblastoma cells, thereby increasing sensitivity 
to doxorubicin treatment [163]. More recently, it was shown that quercetin inhibits 
HSF1, downregulates Hsp70, and facilitates tumor radiofrequency ablation in rats 
[164]. Notably, quercetin inhibits many kinases, including JNK and p38 MAPK [165]. 
It is thus possible that through inhibition of these kinases, quercetin may lead to a 
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decrease in the activating phosphorylation modifications within HSF1, thereby 
decreasing its transcriptional activity.  
Au et al. [166] have developed a high-content imaging-based screening assay 
for the identification of HSF1 inhibitors based on the quantification of the formation 
of HSF1/Hsp70 granules that form in HeLa cells after heat shock. Initially, the 
authors screened a library of 1,300 compounds and identified a compound of an 
undisclosed structure with an IC50 value of 80 nM, which was shown to inhibit HSF1 
phosphorylation and decrease the expression levels of Hsp70 and Hsp90. Very 
recently, the same strategy was used to screen a library of 100,000 compounds, and a 
number of inhibitors were identified, among which the most potent compound, 
PW3405 (Fig. 9) had an IC50 value of 240 nM [167]. Immunoblotting analysis 
confirmed that, similar to quercetin, these compounds were able to inhibit the 
activating HSF1 phosphorylation at serine 326, suggesting that kinase inhibition may 
underlie their mechanism of action. 
Small molecules that inhibit HSF1 without affecting the phosphorylation of 
the transcription factor have also been reported. One example is the phytochemical 
triptolide (Fig. 9), a diterpene triepoxide derived from Triptergium wilfordii. 
Curiously, this is the same plant that is also a source of the HSF1 activator celastrol. 
At nanomolar concentrations, triptolide reversibly inhibits HSF1-dependent 
transcription in HeLa cells stably expressing the human HSP70 promoter-driven 
luciferase reporter, and enhances apoptosis induced by severe heat shock [168]. 
Triptolide treatment prevents the inducible expression of heat shock genes by a 
mechanism that is not fully understood, but involves abrogation of the transactivation 
function of HSF1 without affecting trimer formation, hyperphosphorylation, or DNA 
binding [168]. In agreement with its HSF1 inhibitory activity, triptolide also decreases 
the formation of HSF1/Hsp70 granules that form in HeLa cells after heat shock [166]. 
By use of a luciferase reporter assay, Yoon et al. [169] screened a library of 
6,230 compounds and identified a compound named KRIBB11 [N2-(1H-indazole-5-
yl)-N6-methyl-3-nitropyridine-2,6-diamine] (Fig. 9) with an IC50 value of 1 µM, 
which was shown to bind HSF1 and inhibit the HSF1-dependent recruitment of 
positive transcription elongation factor b (p-TEFb) to the HSP70 promoter. Most 
recently, using an HSE-driven reporter-based chemical screen of more than 300,000 
compounds in cells subjected to proteotoxic stress by treatment with the proteasome 
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inhibitor MG132, Santagata et al. [170] identified the protein translation initiation 
inhibitor rocaglate and a number of its analogs as inhibitors of HSF1 activation. The 
most potent compound had an IC50 value of 20 nM, and was named rohinitib (Fig. 9) 
(or RHT: Rocaglate, Heat Shock, Initiation of Translation Inhibitor). The levels of 
HSF1 in the cell did not change upon exposure to RHT. However, chromatin 
immunoprecipitation coupled with massively parallel DNA sequencing (ChIP-Seq) 
analysis revealed that RHT abolished HSF1 binding to DNA throughout the genome. 
Most recently, 200,000 small molecules (consisting of 35,000 kinase-directed 
compounds and a diversity set of 165,000 compounds from the AstraZeneca 
collection) underwent a phenotypic screen in the U2OS human osteosarcoma tumour 
cell line treated with 17-allylamino-17-demethyoxygeldanamycin (17-AAG), an 
Hsp90 inhibitor which triggers the HSR causing upregulation of Hsp70 [171]. The 
screen identified a 4,6-disubstituted pyrimidine derivative, and after optimization in 
an extensive structure-activity relation study based on the 4,6-pyrimidine scaffold, the 
resulting piperidine analog (Fig. 9) had an IC50 value of 15 nM. Interestingly, this 
compound was also a highly potent inhibitor of cyclin-dependent kinase 9 (CDK9). 
To test the possibility that CDK9 inhibition could be involved in inhibiting HSF1, two 
other structurally distinct validated CDK9 inhibitors were tested and found to be 
potent inhibitors of the HSF1-mediated HSR. One of these compounds, SNS-032 (Fig. 
9), had been previously shown to inhibit HSF1-dependent induction of Hsp72 
following treatment of A549 human non-small cell lung carcinoma cells with the 
Hsp90 inhibitor ganetespib [172]. It is currently unknown whether CDK9 affects the 
HSF1 activity directly, by catalyzing activating phosphorylation modifications within 
the transcription factor, or indirectly, in its capacity as a component of the positive 
transcription elongation factor b (P-TEFb), which stimulates transcription by 
phosphorylating RNA polymerase II. 
 
Concluding Remarks  
The efforts of many investigators have led to the current understanding of the 
existence of multiple layers of regulation of HSF1, including post-translational 
modifications (phosphorylation, sumoylation, and acetylation), proteasomal 
degradation, as well as the modulation of this transcription factor by small molecule 
activators and inhibitors. Because the function of HSF1 is dysregulated in a number 
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of human pathologies, including cardiovascular and neurodegenerative diseases and 
cancer, as well as during ageing, small molecule pharmacological modulators 
represent potential drug candidates. It should be pointed out that none of the known 
HSF1 modulators (activators or inhibitors) are specific, highlighting the fact that 
HSF1 does not operate in isolation, but in concert with other protein partners and 
stress-response transcription factors. One prominent example is transcription factor 
nuclear factor-erythroid 2 p45-related factor 2 (NRF2), which controls the gene 
expression of networks of antioxidant, drug-metabolizing, anti-inflammatory, and 
metabolic proteins, providing an interface between redox and intermediary 
metabolism [173]. A large number of studies suggest the existence of crosstalk 
between NRF2- and HSF1-regulated cytoprotective responses; these studies have 
been recently reviewed [174]. Global transcriptional profiling and proteomics 
analyses have consistently shown that, in addition to activating HSF1, most of the 
inducers discussed above, both naturally occurring as well as synthetic, also activate 
NRF2. It is thus very likely that together, the transcriptional programs orchestrated by 
HSF1 and NRF2 mediate the overall cytoprotective effects of these dual activators. 
Sulfhydryl reactivity is a common feature of these compounds and plays a critical role 
in the activation of both transcription factors, although the inducer concentrations that 
are required to activate HSF1 are generally higher than those that activate NRF2. The 
recognition of the importance of sulfhydryl reactivity of small molecule activators has 
been instrumental for elucidating the mechanisms by which HSF1 and NRF2 are 
regulated. Further research is needed to identify the precise points of crosstalk 
between these cytoprotective mechanisms and be able to determine suitable 
intervention strategies for their targeting for disease prevention and treatment. 
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Figure Legends 
Figure 1. Functional domain structure of HSF family members (HSF1-4) across 
different species. Shown are are the DNA-binding domain (DBD, green), the leucine 
zipper domain 1-3 (LZ1-3, blue), the regulatory domain (RD, yellow), the leucine 
zipper 4 domain (LZ4, blue) and the C-terminal transactivation domain (CTAD, 
orange). The uncharacterized domains are colored in pink.  
Figure 2. Molecular phylogenetic analysis of HSF family members by the Maximum 
Likelihood method. The evolutionary history was inferred by using the Maximum 
Likelihood method based on the JTT matrix-based model [175]. The tree with the 
highest log likelihood (-15403.2303) is shown. Initial tree(s) for the heuristic search 
were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a 
matrix of pairwise distances estimated using a JTT model, and then selecting the 
topology with superior log likelihood value. The tree is drawn to scale, with branch 
lengths measured in the number of substitutions per site. The analysis involved 17 
amino acid sequences. All positions containing gaps and missing data were 
eliminated. There were a total of 450 positions in the final dataset. Evolutionary 
analyses were conducted in MEGA7 [176]. The mouse, rat, dog, human, bovine, and 
chicken HSFs are abbreviated with mHSF, rHSF, dHSF, hHSF, bHSF and cHSF, 
respectively. The HSF sequences were obtained from the UniProt database 
(uniprot.org). UniProt IDs: mHSF1-4 (P38532, P38533, D0VYS2 and Q9R0L1), 
rHSF(1-2 and 4) (Q63717, Q9R120 and A0A096MK39), dHSF4 (Q1HGE8), 
hHSF(1-2 and 4) (Q00613,  Q03933 and Q9ULV5), bHSF(1-2 and 4) (Q08DJ8, 
A4FUA9 and F1MVT6) and cHSF(1-3) (P38529, P38530 and P38531). 
Figure 3. The heat shock response. Various types of cellular stressors such as heat 
and proteotoxicity can activate the heat shock response by causing the release of the 
transcription factor HSF1, which in unstressed conditions is basally sequestered by 
the Hsp90 multichaperone complex that includes the co-chaperone Hsp70. In 
addition, the binding between the leucine zipper (LZ) domains LZ1-3 and LZ4 of 
HSF1 is disrupted, and the regulatory domain (RD) becomes hyperphosphorylated. 
The activated HSF1 enters the nucleus, homotrimerizes, and binds to the heat shock 
elements (HSEs) to induce the transcription of its target genes. HSF1 that is present in 
the nucleus also becomes activated upon stress and is able to homotrimerize to elicit 
the heat shock response. In the attenuation phase, Hsp70 present in the nucleus is able 
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to bind to the C-terminal transactivation domain  (CTAD) of HSF1 to inhibit its 
function. During this time HSF1 is also dephosphorylated and shuttles out of the 
nucleus, resumes its inactivated form and is once again bound to the Hsp90 
multichaperone complex. 
Figure 4. Schematic diagram of the structure and posttranslational modifications of 
HSF1. The activating modifications (blue) are phosphorylation (Ph) modifications on 
serine residues 230, 326, and 419. The repressive modifications (red) on HSF1 are 
acetylation (Ac) on lysine 80, phosphorylation on Ser serine 121, 172, 303, 307 and 
363 and sumoylation (Su) on lysine 298. The enzymes that catalyze these 
modifications are indicated beside the respective residue modifications; DBD, N-
terminal DNA-binding domain; LZ, Leucine zippers LZ1-3 and LZ4; RD, Regulatory 
domain; CTAD, C-terminal transactivation domain. Trimerization of HSF1 occurs at 
the LZ1-3 region, which during basal conditions is negatively regulated by LZ4. In 
addition, under unstressed conditions, the CTAD is negatively regulated by the RD. 
Figure 5. Crystal Structure of the DNA-binding domain (DBD) of human HSF1 
(amino acids 10-123). The domain is colored according to the secondary structure of 
the protein where the alpha helices and beta sheets are represented by red and yellow, 
respectively. Amino acid residues lysine 80 (K80) and serine 121 (S121) are 
represented in blue. Figure drawn with Pymol using the PDB entry 2LDU. 
Figure 6. Endogenous small molecule activators of HSF1. 
Figure 7. Phytochemical activators of HSF1. 
Figure 8. Synthetic small molecule activators of HSF1. 
Figure 9. Small molecule inhibitors of HSF1. 
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